At this occasion, Oncobiome will deliver the GOMS in 2L locally advanced or metastatic lung cancer patients (Dr Routy, Dr Derosa, Dr Bonvalet, GR-Montréal, data mining by Dr Iebba, Dr A. Thomas, Dr N. Segata) as well as melanoma GOMS associated with the efficacy or resistance to DC-based vaccines
(Dr J. De Vries).
